Table 3.
Pathogen | Age group (year) | Total (%) | ||
---|---|---|---|---|
<5 (%) | 6–10 (%) | 10–12 (%) | ||
RV | 3 (1.7) | 1 (0.6) | 0 (0.0) | 4 (2.3) |
BV | 2 (1.1) | 1 (0.6) | 1 (0.6) | 4 (2.3) |
RSV A/B | 2 (1.1) | 1 (0.6) | 1 (0.6) | 4 (2.3) |
AV | 1 (0.6) | 0 (0.0) | 0 (0.0) | 1 (0.6) |
MPV A/B | 1 (0.6) | 0 (0.0) | 0 (0.0) | 1 (0.6) |
M. pneumoniae | 1 (0.6) | 0 (0.0) | 0 (0.0) | 1 (0.6) |
PIV-1 | 1 (0.6) | 0 (0.0) | 0 (0.0) | 1 (0.6) |
PIV-3 | 1 (0.6) | 0 (0.0) | 0 (0.0) | 1 (0.6) |
CoV-OC43 | 2 (1.1) | 0 (0.0) | 0 (0.0) | 2 (1.1) |
CoV-HKU1 | 2 (1.1) | 1 (0.6) | 1 (0.6) | 4 (2.3) |
RV, rhinovirus; BV, bocavirus; RSV A/B, respiratory syncytial virus A-B; AV, adenovirus; MPV A/B, metapneumovirus A-B; M. pneumoniae, Mycoplasma pneumoniae; PIV-1, parainfluenza virus-1; PIV-3, parainfluenza virus-3; CoV-OC43, coronovirus-OC43; CoV-HKU1, coronavirus-HKU.